Image of The safety of antithrombotic therapy in patients with cerebral microbleeds and cardiogenic cerebral embolism due to nonvalvular atrial fibrillation

LITERATURE

The safety of antithrombotic therapy in patients with cerebral microbleeds and cardiogenic cerebral embolism due to nonvalvular atrial fibrillation


The impact of cerebral microbleeds on the safety of antithrombotic therapy has recently received
considerable attention. We investigated the safety of antithrombotic therapy in patients with cerebral microbleeds
and cardiogenic cerebral embolism caused by nonvalvular atrial fibrillation


Availability

REQJ4198Available

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
BMC Cardiovascular Disorders (2019) 19:77
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous